openPR Logo
Press release

Lung Cancer Screening Software Market Analysis by PenRad Technologies Inc., Koninklijke Philips N.V., Volpara Solutions Limited, Lungview, Siemens Healthcare Private Limited, Thynk Health

08-04-2020 03:44 PM CET | Health & Medicine

Press release from: Data Bridge Market Research

Lung Cancer Screening Software Market

Lung Cancer Screening Software Market

Lung Cancer Screening Software Market research report contains complete background analysis of industry, which includes an assessment of the parental market. All the statistical and numerical that has been forecasted in this business report is represented with the help of graphs, charts, or tables which makes this report more user friendly. The report contains thorough description, competitive scenario, wide product portfolio of key vendors and business strategy adopted by competitors along with their SWOT analysis and porter's five force analysis. Whether it is about renewing a business plan, preparing a presentation for a key client, or giving recommendations to an executive, this large scale Lung Cancer Screening Software Market report will surely help to a degree.

Get Sample Copy of this Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-lung-cancer-screening-software-market

Lung Cancer Screening Software Market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a CAGR of 19.2% in the forecast period of 2020 to 2027 and is expected to reach USD 80,455.86 thousand by 2027 due to the increasing prevalence of lung cancer cases globally, increasing awareness regarding the benefits of early diagnosis and frequent screening, government initiatives undertaken to implement screening programs for various diseases are the major drivers which propelled the demand of the market in the forecast period.

The major players covered in the report are Medtronic, PenRad Technologies Inc., Koninklijke Philips N.V., Volpara Solutions Limited, Lungview, Siemens Healthcare Private Limited, Thynk Health, Eon, Nuance Communications, Inc., MeVis Medical Solutions AG, Vital Images (A Subsidiary of Canon Group company), HealthMyne, Optellum Ltd, Coreline Soft, Co., Ltd., MyCareWare, ProVation Medical, Inc. and among other domestic and global players.

Table of Contents

Executive Summary

Assumptions and Acronyms Used

Research Methodology

Market Overview

Global Market Analysis and Forecast by Types

Global Market Analysis and Forecast by Applications

Global Market Analysis and Forecast by Regions

North America Market Analysis and Forecast

South America Market Analysis and Forecast

Europe Market Analysis and Forecast

Asia Pacific Market Analysis and Forecast

Middle East & Africa Market Analysis and Forecast

Competition Landscape

Access Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-lung-cancer-screening-software-market

Global Lung Cancer Screening Software Market Scope and Market Size

Global lung cancer screening software market is segmented into eight notable segments which are based on mode of delivery, product, type, application, platform, purchase mode, end user, and distribution channel.

On the basis of mode of delivery, the lung cancer screening software market is segmented into cloud based solutions, on-premise solutions, and web based solutions.

On the basis of product, the lung cancer screening software market is segmented into lung cancer screening radiology solution, lung cancer screening patient management software, nodule management software, data collection and reporting, patient coordination and workflow, lung nodule computer aided detection, pathology and cancer staging, statistical audit reporting, screening PACs, practice management, and audit log tracking.

On the basis of type, the lung cancer screening software market is segmented into computer-assisted screening and traditional screening.

On the basis of application, the lung cancer screening software market is segmented into non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC).

On the basis of platform, the lung cancer screening software market is segmented into standalone and integrated.

On the basis of purchase mode, the lung cancer screening software market is segmented into individual and institutional.

On the basis of end user, the lung cancer screening software market is segmented into hospitals, oncology centers, ambulatory surgical centers, and others.

On the basis of distribution channel, the lung cancer screening software market is segmented into direct tenders, and third party distributor.

Lung Cancer Screening Software Market Country Level Analysis

The countries covered in the lung cancer screening software market report are the U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Switzerland, Netherlands, Belgium, Russia, Turkey and rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines and rest of Asia-Pacific, Brazil, Argentina and rest of South America, South Africa, Saudi Arabia, U.A.E., Israel, Egypt and rest of Middle East and Africa.

North America holds majority of the share in the lung cancer screening software marketing system, with key market players expanding their products and promoting ongoing strategic partnerships that account for the largest share of the population in the region. Increasing the market growth in health spending in China and India, increasing the incidence of lung cancer and improving healthcare infrastructure in Southeast Asian countries are key factors. Additionally, the increasing number of COVID 19 cases is expected to accelerate economic growth during the forecast period.

Competitive Landscape and Lung cancer screening software Market Share Analysis

Lung cancer screening software market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to lung cancer screening software market.

Order a Copy of Global Lung Cancer Screening Software Market Report @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-lung-cancer-screening-software-market

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: Corporatesales@databridgemarketresearch.com

About Data Bridge Market Research

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. We ponder into the heterogeneous markets in accord with our clients needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delve into the markets across Asia, North America, South America, Africa to name few.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lung Cancer Screening Software Market Analysis by PenRad Technologies Inc., Koninklijke Philips N.V., Volpara Solutions Limited, Lungview, Siemens Healthcare Private Limited, Thynk Health here

News-ID: 2103045 • Views:

More Releases from Data Bridge Market Research

Water Treatment System Market: Sustaining the Future of Clean Water
Water Treatment System Market: Sustaining the Future of Clean Water
Introduction Understanding Water Treatment Systems Water treatment systems are designed to purify and disinfect water for various uses-drinking, industrial processes, irrigation, and wastewater reuse. These systems eliminate contaminants such as bacteria, viruses, heavy metals, chemicals, and particulates, making water safe and sustainable for consumption and use. Importance in Global Sustainability Clean water is essential to life and industrial progress. With growing water demand and pollution, water treatment systems are now critical infrastructure across the
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032. With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032. With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032. With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal

All 5 Releases


More Releases for Lung

Lung Cancer Prevalence Driving The Lung Cancer Drugs Market: Core Growth Enabler …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Lung Cancer Drugs Industry Market Size Be by 2025? The market for lung cancer medications has seen a swift expansion in previous years. The market size is projected to escalate from $47.94 billion in 2024 to $54.13 billion in 2025, with a compound annual growth rate
Lung Cancer Prevalence Driving The Lung Cancer Drugs Market: An Emerging Driver …
The Lending And Payments Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Projected Growth of the Lending And Payments Market? The lending and payments market has experienced strong growth in recent years. It is set to rise from $12,326.44 billion in 2024 to
Transforming the Lung Cancer Drugs Market in 2025: Lung Cancer Prevalence Drivin …
What Is the Expected Size and Growth Rate of the Lung Cancer Drugs Market? The market size for lung cancer medications has seen swift expansion in the recent past. Its growth is projected to surge from $47.94 billion in 2024 to $54.13 billion in 2025, marking a compound annual growth rate (CAGR) of 12.9%. Factors contributing to the historical period's growth include epidemiology and demographics, regulatory authorizations, healthcare system infrastructure, and
Transforming the Lung Cancer Drugs Market in 2025: Lung Cancer Prevalence Drivin …
What Is the Expected Size and Growth Rate of the Lung Cancer Drugs Market? The market size for lung cancer medications has seen swift expansion in the recent past. Its growth is projected to surge from $47.94 billion in 2024 to $54.13 billion in 2025, marking a compound annual growth rate (CAGR) of 12.9%. Factors contributing to the historical period's growth include epidemiology and demographics, regulatory authorizations, healthcare system infrastructure, and
Lung Cancer Screening Market - Empowering Proactive Lung Health: The Future of C …
Newark, New Castle, USA: The "Lung Cancer Screening Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Lung Cancer Screening Market: https://www.growthplusreports.com/report/lung-cancer-screening-market/7787 This latest report researches the industry structure,
Artificial Lung Market May Set New Growth Story | Breethe, Lung Biotechnology, M …
A new research document is added in HTF MI database of 37 pages, titled as 'Artificial Lung - Medical Devices Pipeline Assessment, 2020' with detailed analysis, Competitive landscape, forecast and strategies. The study covers important players/vendors such as ALung Technologies Inc, Breethe, Inc., Case Western Reserve University, Lung Biotechnology PBC, MC3 Inc, McGowan Institute for Regenerative , Medicine, Miromatrix Medical Inc, The Charles Stark Draper Laboratory Inc, U.S. Ann Arbor